P299 - A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin ineligible muscle invasive bladder cancer

Autor: Satkunasivam, R., Teh, B.S., Riveros, C., Lim, K., Wallis, C.J.D., Hu, S., Melchiode, Z., Nikolos, F., Miles, B.J., Kaushik, D., Chen, S.H., Efstathiou, E., Chan, K.S., Esnaola, N.F., Sonpavde, G.P.
Zdroj: In European Urology March 2024 85 Supplement 1:S415-S415
Databáze: ScienceDirect
Externí odkaz: